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Summary.This review highlights recent findings on the evolutionary arms race between the causative agent of cholera Vibrio 
cholerae and virulent bacteriophages (phages) ICP1, ICP2, and ICP3 isolated from cholera patient stool samples. We discuss 
mechanisms of phage resistance such as a unique phage-inhibitory chromosomal island and mutations that affect phage receptor 
expression. We also discuss the molecular characterization of ICP1 and its unique CRISPR-Cas system, which it uses to combat 
the phage-inhibitory chromosomal island. The role of phages in the life cycle of V. cholerae has been increasingly recognized and 
investigated in the past decade. This article will review hypotheses as to how the predator-prey relationship may have an impact 
on infections within individuals and on the self-limiting nature of cholera epidemics. In addition, we put forth a strategy of using 
phages as an intervention to reduce household transmission of cholera within a community. 
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Introduction
Bacteriophages, or phages for short, are found throughout the 
biosphere. There are an estimated 1031 phages in the world [18]. 
As viruses of bacteria, phages play an important role in the 
regulation of bacterial populations. Indeed, when phages were 
first discovered by Felix d’Herelle in 1917, he proposed that 
the predator-prey relationship may contribute to controlling 
the natural population of pathogens such as Vibrio cholerae, 
the causative agent of cholera [6]. Cholera is an acute gas-
trointestinal disease that is characterized by the rapid onset 
of vomiting and profuse, secretory diarrhea. It is caused by 
ingestion of water or food that has been contaminated with V. 
cholerae, a Gram-negative bacterium that resides in brackish 
coastal waters and estuaries [14]. Cholera is a significant burden 
on global health, particularly in developing countries where 
water sanitation services are not readily accessible. The World 
Health Organization estimates that there are approximately 2.8 
million cases of cholera each year in endemic countries, which 
are predominantly in Africa and Asia [1]. 
Cholera is an ancient disease; descriptions in Sanskrit of 
cholera-like symptoms have been found and dated back to the 
5th century BC. Sometimes referred to as “Asiatic cholera”, it 
has been endemic in South Asia, especially the Ganges delta 
region, since recorded history [32]. Naturally, populations of 
phages capable of infecting V. cholerae also are present in chol-
era-endemic regions. Before phages were identified, historical 
reports note that there were certain elements in the Ganges and 
Yamuna Rivers in India that can protect against cholera. In 
1896, Ernest Hankin passed the water through fine porcelain 
filters and suggested that there was an unidentified substance in 
the filtrate that is responsible for killing V. cholerae. He further 
hypothesized that it perhaps plays a role in limiting the spread 
of cholera epidemics [13,33]. 
D’Herelle also identified phages from cholera patient stool 
samples during his work in the 1920s and used them to launch 
a phage therapy trial in India known as “The Bacteriophage 
Inquiry” [34]. Initial reports showed consistent observations 
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that oral phage therapy resulted in reduced severity and duration 
of cholera symptoms as well as a decrease in mortality rates [8]. 
When phages were added to water wells, there were no further 
cases in villages that previously had cholera [7]. The sum of 
these results suggested that the introduced phage populations 
were capable of controlling the V. cholerae population in both 
clinical and environmental contexts. 
Since then, there have been a number of cholera phage collec-
tions maintained globally. Phage typing has been used to identify 
V. cholerae strains and has contributed greatly to understanding 
cholera epidemiology. In 1968, Basu and Mukerjee developed a 
typing scheme using five groups of phages, allowing them to suc-
cessfully identify 3,464 strains from different epidemics between 
1937 and 1966 [2]. Additional updated phage collection schemes 
[3,4]. There are also a large number of cholera phages stored at 
the Eliava Institute in Tbilisi, Georgia, the majority of which 
were isolated from aquatic environments. A recent publication 
mentions that there are 71 phages collected from 2006 to 2009 
alone [9]. Similar collections are maintained at institutions in 
Russia and China as well.
In recent years, there has been a renewed interest in chol-
era phages and their study using modern molecular methods 
[10,23,28]. At the International Centre for Diarrhoeal Disease 
Research, Bangladesh (ICDDR,B), Faruque et al. have isolated 
at least 18 cholera phages, known as the JSF series [12]. Our lab 
has isolated and sequenced the genomes of three distinct phag-
es, referred to as the ICP phages, from 31 Bangladeshi clinical 
stool samples that span a 10-year period from 2001 to 2010 
[28]. This review will discuss the co-evolutionary dynamics 
between V. cholerae and the ICP phages as well as implications 
for the role of phage in cholera epidemics. 
The discovery of the ICP phages
Through a collaboration with the ICDDR,B and Massachusetts 
General Hospital (MGH), a postdoctoral scholar in our lab at 
the time, Dr. Kimberley Seed, tested clinical samples for phage 
presence by plaque assay. Three novel, virulent phages were 
identified and designated as ICP1, ICP2, and ICP3 (Table 1). 
ICP1 is specific for O1 serogroup V. cholerae; however, the host 
ranges for ICP2 and ICP3 are broader and include some non-O1 
serogroup V. cholerae strains. Using primers specific for the DNA 
polymerase gene of each phage, Dr. Seed screened total DNA 
from the cholera patient stool samples by PCR to determine 
prevalence. While the presence of ICP2 and ICP3 were more 
sporadic, ICP1 was present in all stool samples tested [28].
Co-evolutionary dynamics between the ICP 
phages and V. cholerae
V. cholerae has evolved multiple strategies to evade phage 
infection. For instance, Zahid et al. have demonstrated how 
down-regulation of cyclic AMP and the cyclic AMP receptor 
protein through mutations in the cyaA or crp genes, respec-
tively, can confer resistance to multiple environmental cholera 
phages from the JSF series [36]. The work in our lab and that 
of Dr. Seed’s in her lab at the University of California, Berkeley 
has focused on understanding the co-evolutionary arms race 
between the ICP phages and V. cholerae through the use of 
comparative genomics and molecular biology approaches. A 
major theme that has emerged from these studies, described 
below, is that the ICP phages have evolved to use cell surface 
receptors that are critical virulence factors of V. cholerae, thus 
limiting the ability of V. cholerae to escape phage predation 
during infection of humans.
ICP1 and the O1 antigen receptor. To identify a 
mechanism for ICP1 resistance, V. cholerae spontaneous 
mutants that formed small colonies within otherwise clear 
zones of plaques were genome sequenced and compared to the 
sequence of the parent strain [29]. Single nucleotide deletions 
were identified in the poly-A tracts of two lipopolysaccharide 
(LPS) O-antigen genes wbeL and manA, which are responsible 
for tetronate and perosamine biosynthesis, respectively. These 
mutations, which shift the reading frame of the genes they 
reside in and cause premature termination, were sufficient to 
confer ICP1 resistance. In addition, purified LPS preparations 
from O1 V. cholerae strains were able to reduce ICP1 plaque 
formation, while those from non-O1 strains were not [28]. Tak-
en together, these lines of evidence suggest that the receptor for 
ICP1 infection is the O1 antigen of V. cholerae LPS.
As in the example above, one mechanism to prevent phage 
infection is eliminating, altering, or reducing the amount of 
Table 1. Genome characteristics of the sequenced ICP phages isolated from cholera patients at the ICDDR,B
Phage Taxonomic family Genome size (bp) G+C content (%) No. of predicted CDSs % CDSs similar to known proteins
ICP1 Myoviridae 125,956 37.1 230 12
ICP2 Podoviridae 49,675 42.7 73 19
ICP3 Podoviridae 39,162 42.9 54 48
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phage receptor on the bacterial surface. Bacteria can modify the 
availability of the receptor through phase variation, allowing 
for a heterogeneous population to ensure survival. The example 
above illustrates this phase variation mechanism, whereby V. 
cholerae undergoes slipped-strand mispairing in the wbeL and 
manA poly-A tracts to modify the availability of its O1 antigen. 
The LPS O1 antigen is normally expressed constitutively and, 
for V. cholerae, is required for intestinal colonization and is 
therefore considered a major virulence factor [5]. Competition 
assays in the infant mouse model of V. cholerae colonization 
were performed to assess the ability of wbeL and manA mutants 
to colonize the small intestine. Both showed decreased fitness, 
with the wbeL mutant being the more severely compromised 
[29]. Therefore, under ICP1 predation, the V. cholerae popu-
lation is forced to survive by shifting towards an attenuated 
virulence phenotype. 
ICP1 and its CRISPR/Cas system. The consistent 
presence of ICP1 in the face of ongoing cholera epidemics in 
Bangladesh, however, implies that V. cholerae has evolved a 
mechanism to resist ICP1 infection while remaining virulent. A 
large fraction of V. cholerae clinical isolates from Bangladesh 
were found to encode an 18-kb phage-inhibitory chromosomal 
island, which is referred to as a phage-inducible chromosomal 
island-like element (PLE) [30]. The PLE is specifically activat-
ed by ICP1 infection and inhibits ICP1 replication. Activation 
includes excision from the chromosome and subsequent repli-
cation as an episome. PLEs can be horizontally transferred by 
natural transformation or by ICP1 transduction [24], the latter 
implying that PLE DNA is packaged into virions. This mech-
anism of phage resistance is akin to abortive infection, where 
the infected cell sacrifices itself to block phage reproduction, 
thus protecting the neighboring cells. 
ICP1 has evolved a mechanism to overcome the PLE defense 
mechanism by encoding a CRISPR/Cas system. CRISPR/Cas 
systems are sequence-specific, adaptive immunity mechanisms 
typically used by bacteria and archaea to protect themselves 
from invading nucleic acids such as phage DNA. However, five 
ICP1 phages, which were isolated from cholera stool samples 
spanning multiple years at the ICDDR,B, encoded a CRISPR/
Cas system with spacers that were 100% identical to sequences 
found within the V. cholerae PLE. The ICP1 CRISPR/Cas is 
also capable of acquiring new spacers during the phage infec-
tion process, which confers specific targeting of new PLE 
sequences and the restoration of ICP1 replication. Therefore, 
ICP1 has successfully co-opted the use of a classically micro-
bial adaptive immune system to allow for its own propaga-
tion within its host, a mechanism that has not previously been 
demonstrated in phages [30].
ICP2 and the OmpU receptor. We previously described 
ICP2 as a virulent phage found sporadically in cholera patient 
stool samples from Bangladesh. While testing for the presence 
of phages within Haitian cholera patient samples, our lab, in 
collaboration with others, identified one sample from 2013 with 
a high titer of phage [31]. Whole-genome sequencing revealed 
this phage to have 84% identity over 93% of its genome to an 
ICP2 isolate from Bangladesh in 2011. The Haitian ICP2 isolate 
is the first lytic phage reported to be associated with epidemic 
cholera in Haiti [31].
Most of the V. cholerae single colony isolates that were recov-
ered from the same clinical sample as the Haitian ICP2 were 
resistant to its infection. By comparative genomics, we deter-
mined that the ICP2-resistant bacteria had mutations in the ompU 
gene, which encodes the major outer membrane porin OmpU. 
Using Western blotting, we determined that wild-type amounts 
of OmpU were present in the outer membranes of these mutants, 
but the mutations were sufficient to confer ICP2 resistance. The 
mutations were mapped onto a predicted membrane topology 
of OmpU and shown to lie within two outer loops, implying 
that they may disrupt the interaction between OmpU and ICP2 
tail fibers [31]. OmpU expression is induced during infection 
where it plays a major role in resistance to organic acids [20], 
anionic detergents [27], bile [35], and antimicrobial peptides 
[19]. A number of assays were performed to determine whether 
the OmpU mutants were attenuated. No detectable reduction in 
fitness was observed in the presence of bile or when the mutants 
were competed with the wild type strain in pond water. There was 
a mild competitive defect for two of the mutants when passaged 
multiple times in LB medium, implying a mild defect in the con-
text of rapid growth and replication [31]. This may explain why 
these ICP2-resistant OmpU variants have not become fixed in 
the V. cholerae population in Bangladesh or Haiti.
ICP2 and the ToxR major virulence gene regula-
tor. Whole-genome sequencing also revealed several ICP2-re-
sistant isolates from Bangladeshi cholera patient stool samples 
with null mutations in the toxR gene. ToxR is the direct tran-
scriptional activator of a number of virulence factors, including 
OmpU. ICP2 sensitivity in the ToxR mutants was restored by 
expressing ompU in trans, indicating that ICP2 resistance is 
mediated through the reduced expression of OmpU. Competi-
tions between each clinical ToxR mutant and its isogenic wild-
type ToxR revertant strain were performed in the infant mouse 
model of cholera, and the null mutants were 100- to 1000-fold 
attenuated [31]. These results are consistent with the inability 
of these mutant ToxR proteins to activate downstream virulence 
genes reported by other labs [21,25], thereby the ICP2-resistant 
ToxR mutants would be attenuated for infection [15]. 
Role of virulent phages in cholera epidemics
Seasonal variations of phage levels in the environment were 
discovered in Kolkata, India as early as 1930 [26]. In endem-
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ic settings, cholera epidemics are self-limiting in nature; it has 
been suggested that virulent phages play a role in modulating the 
course of epidemics [10,11,16,22,23]. Based on epidemiological 
data collected from Dhaka, Bangladesh, Faruque et al. developed 
a model suggesting that virulent phages can attenuate cholera 
epidemics [16]. This model, which is based on observations that 
the rise of V. cholerae in the environment at the peak of epidemics 
is usually followed by a rise of cholera phages, suggests that the 
bloom of cholera phages reduces the V. cholerae population to 
the point that the epidemic peters out. A critical assumption of 
this model is that the initial drop in cholera cases should coincide 
with high levels of ambient phage. This assumption has been 
challenged by King et al., as the data show that the number of 
cholera cases began to decline while the phage numbers were 
still low [17]. Doubtless, phage predation plays a critical role 
within patients during the course of cholera infection as well as 
in its transmission to others or to the environment. More detailed 
clinical data are needed, however, before a causal role for phages 
in limiting cholera epidemics can be drawn.
Conclusions
In this review, we have discussed recent literature regarding 
the arms race between V. cholerae and its phages in the con-
text of infection. Adaptations to phage predation are shown 
to involve trade-offs in fitness, which can impact virulence, 
transmission, and seeding of environmental reservoirs. By fur-
ther understanding and characterizing the molecular mecha-
nisms of these predator-prey relationships, we envision using 
phages as a rapid-acting intervention for at-risk populations, 
such as household contacts of cholera patients, to immediate-
ly protect against contracting the disease themselves. In this 
manner, phage prophylaxis can represent a fast and specific 
tool to reduce the burden of bacterial infections on global 
health.
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